The translabrynthine approach is used to surgically remove vestibular schwannomas. It provides the most direct exposure of the cerebellopontine angle but results in total hearing loss. The key steps involve complete mastoidectomy and labyrinthectomy to access the internal auditory canal. This allows for identification and preservation of the facial nerve while fully exposing the tumor for removal. Though it sacrifices any residual hearing, it allows for quick recovery and excellent postoperative facial nerve function outcomes.
Perilymph Fistula can be difficult to diagnose as a standalone condition. Post-trauma symptoms such as dizziness, headache, etc. can be linked to other conditions like a traumatic brain injury with a concussion.
Inner ear malformations and ImplantationUtkal Mishra
This slide vividly describes relevant anatomy & embryology of cochlea. It gives the reader insights into various cochlear malformations & implantation.
Spaces of middle ear and their surgical importanceDr Soumya Singh
one of the imp topics in ENT that should be understood very thoroughly if u want to pursue as an otologist.I tried to simplify the topic with simple diagrams and models for better understanding .
Cavity obliteration is a procedure done at the end of Mastoidectomy to get a cavity-less mastoid cavity thus solving the problem of discharging post-operative cavity.
Perilymph Fistula can be difficult to diagnose as a standalone condition. Post-trauma symptoms such as dizziness, headache, etc. can be linked to other conditions like a traumatic brain injury with a concussion.
Inner ear malformations and ImplantationUtkal Mishra
This slide vividly describes relevant anatomy & embryology of cochlea. It gives the reader insights into various cochlear malformations & implantation.
Spaces of middle ear and their surgical importanceDr Soumya Singh
one of the imp topics in ENT that should be understood very thoroughly if u want to pursue as an otologist.I tried to simplify the topic with simple diagrams and models for better understanding .
Cavity obliteration is a procedure done at the end of Mastoidectomy to get a cavity-less mastoid cavity thus solving the problem of discharging post-operative cavity.
This is a presentation I used for my seminar on 'Phonosurgery' on 4th November, 2015. I hope they are useful to you. Constructive as well as Destructive criticism welcomed.
This is a presentation I used for my seminar on 'Phonosurgery' on 4th November, 2015. I hope they are useful to you. Constructive as well as Destructive criticism welcomed.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
2. INTRODUCTION
An acoustic neuroma (also called
vestibular schwannoma) is a
benign tumor arising from
abnormally proliferative shwann
cells , which envelope the lateral
portion of the vestibular nerve in
4. CP angle tumors
Represents 10 % of all intracranial
tumors.
Fatal without treatment.
VS account for 78 % of CPA tumors
- mostly from vestibular branch of
VIIIth Nerve.
Variety of other tumors arise from
this area like meningioma , CN
swannomas , dermoid tumors ,
arachnoid cysts ,lipomas ,
5. Anatomy of CP angle
CPA – Irregularly shaped potential
space in the posterior fossa of the
brain .
Anteriorly – posterior surface of
temporal bone .
Posteriorly – anterior surface of the
cerebellum.
Medially – cisterns of the pons &
medulla and olive.
Superiorly – inferior border of pons
6.
7.
8. Anatomy of CP angle
CN s V ( superiorly ) , IX,X,XI
(inferiorly ) transverse the cephalic
and caudal extent of the CPA.
The central structures crossing the
CPA to & from the IAC are CN VII &
VIII s carrying with them a fine
sheet of arachnoid tissue upto IAC.
Schwann cells sorround these
nerves beginning in the IAC , near
the porus at the Obersteiner-
Redlich zone.
9. Anatomy of CP angle
CN s V ( superiorly ) , IX,X,XI
(inferiorly ) transverse the cephalic
and caudal extent of the CPA.
The central structures crossing the
CPA to & from the IAC are CN VII &
VIII s carrying with them a fine
sheet of arachnoid tissue upto IAC.
Schwann cells sorround these
nerves beginning in the IAC , near
the porus at the Obersteiner-
Redlich zone.
10. Anatomy of CP angle
AICA is the main artery in the
CPA and is the source of the
labrynthine artery .
The labrynthine artery
courses via the IAC & is an
end artery for the hearing and
balance organs.
11. Vestibular schwannoma
Nerve sheath tumors of the
superior and inferior
vestibular nerves.
They arise in the medial part
of the IAC or the lateral part
of the CPA and cause clinical
symptoms by displacing ,
distorting or compressing
12. Vestibular schwannoma
Mean incidence range – 9.1 tmr/yr to
13 tmr/yr( as per SB)
0.7 to 1.2 VS per lakh population/yr (
ballenger )
Types - Sporadic ( 95%) and non
sporadic ( 5%)
Age of presentation – 40 to 60 yrs.
Age of presentation is less in non
sporadic ( 20-30 yrs )
13. Tumor biology
Equal frequency in sup and inf
vestibular ( but recent japanese
studies suggested 85 % from inf
vestibular )
Arise from schwann cells within
the IAC – lateral to O-R zone in the
area of scarpa ganglion.
Schwannomas rarely arise from
the cochlear nerve & are rarely
14. Tumor pathogenesis
Owing to mutations in the gene for
the tumor suppresor protein MERLIN
located on chr 22q12.
Formation of VS requires mutation of
both copies of the merlin gene.
Somatic mutations in both copies of
merlin gene results in sporadic VSs .
Familial VS occuring in NF 2 requires
only one somatic mutation event .(
inherit one )
15. Tumor pathogenesis
NF2 is autosomal recessive at gene
level but inheritance is autosomal
dominant ( pseudodominant )
A mutation in the normal allele leads
to bilateral VS by the age of 20.
Genetic screens for the NF2 mutation
have been developed and are the basis
for genetic counselling for family
members of NF2 patients
16. Tumor pathogenesis
Biochemical factors- VS express
neuregulin ,which controls survival
and proliferation of schwann cells and
its receptors erbB2 & erbB3.
FGF ,TGF B1 , PDGF & VEGF all these
contribute to VS proliferation.
VS may accelerate during pregnancy.
17. pathology
GROSS :
◦ VS have a smooth surface with a yellow to
gray color.
◦ Tumor is usually solid ,with occasional
cystic components and therefore has a
firm to soft texture depending on solid to
cystic components.
MICROSCOPIC :
◦ Capsule – 3 to 5 micrometer in thickness.
◦ Two morphological tissue types – Antony
A & Antony B areas
18. T UMOR DEVELOPMENT
Develops in nerve sheath
Compresses rather than invading the
nerve
Gradually fills all the IAC
Protrudes out of the porus
19. T UMOR DEVELOPMENT-
extrameatally
Extrameatal expansion into the large &
empty pontine cistern
Displacement and stretching of the VII &
VIII th CN on the anterior
Compress cerebellum and trigeminal N
aspect of the tumor & of the AICA
on the inferior aspect
(During this time IAM continues to become
more & more widened )
which leads gradually to
hydrocephalus
20. T UMOR DEVELOPMENT-
extrameatally
Tumor may extent to the tentorium & can
obstruct the
cochlear aqueduct
The AICA & lower cranial nerves are also
displaced & become closely
Overtime , the trigeminal & abducens
Adherent to the inf surface of
tumor.
over the surface of the tumor and
get thinned.
22. Tumor development…..
Periods of growth are intermixed
b/w slow growth & peroid of
quescence.
Occasionally tumor may undergo
rapid expansion owing to cystic
degeneration or hemmorhage into
the tumor.
The initial intracanalicular growth
effects the vestibulocochlear nerve
27. Large Acoustic Neuroma: Tumors over 2.5 centimeters (this one is 2.6 cm) become impacted
into the brainstem and cerebellum. Complications associated with surgery and radiation are
higher. It is difficult to deliver an adequate dose of radiation to control tumor growth without
excessive dosing to the brainstem in tumors larger than this.
28.
29. Symptoms & signs
Intracanalicular:
◦ Hearing loss (UL progressive ), tinnitus, vertigo
◦ Loss of speech discrimination out of propotion to HL
Cisternal:
◦ Worsened hearing and dysequilibrium
Compressive:
◦ Occasional occipital headache
◦ CN V: Midface, corneal hypesthesia
◦ CN VII : Hitzelberger’s sign, loss of taste and reduced
lacrimation on Schirmer’s test ,facial weakness ( late)
◦ CN II , IV , VI : visual acquity and diplopia
30. Symptoms & signs
Hydrocephalic:
◦ Fourth ventricle compressed and obstructed
◦ Headache, visual changes, altered mental status
◦ Nausea and vomiting
◦ On examination : ICP and pappiledema.
Compression of CN IX & X
◦ Dysphagia , aspiration and hoarseness
◦ Poor gag reflex and VC paralysis.
Cerebellar involvement( late )
◦ Incoordination , widely based gate , tendency to fall
owards affected side
31. Symptoms & signs
Brainstem involvement:
• There is ataxia, weakness and numbness of arms and legs
with exaggerated tendon reflexes.
32. Jackler Staging System
STAGE TUMOUR SIZE
Intra canalicular Tumour confined to IAC
I (Small) <10mm
II(Medium) 11-25mm
III(Large) 25-40mm
IV(Giant) >40mm
34. Duration of Symptoms Prior to
Diagnosis
SYMPTOMS YEARS
Hearing loss 3.9
Vertigo 3.6
Tinnitus 3.4
Headache 2.2
Dysequilibrium 1.7
Trigeminal 0.9
Facial 0.6
35. Diagnostic evaluation
Average patient will require 4 years from the
onset of symptoms to diagnosis.
Majority will present with complaints of UHL, UT,
Vertigo , dysequilibrium, facial numbness ,
weakness or spasm.
Initial step in evaluation includes an audiologic
assessment .if it suggests a retrocochlear lesion ,
then imaging of the CPA is performed .
Vestibular testing lacks specificity in diagnosis of VS
36. AUDIOLOGICAL EVALUATION
Includes PTA , Speech discrimination score
(SDS) , Acoustic reflex threshold & acoustic
reflex decay
PTA of patients with VS shows assymetric ,
down sloping , high frequency SNHL in almost
70% of patients
37. AUDIOLOGICAL EVALUATION
Retrocochlear HL causes SDS to be lower than
predicted by the pure tone thresholds.
This out of propotion is furthur accenuated
when retested at a higher speech intensity
( roll over phenomenon )
Loss of acoustic reflex or acoustic reflex decay is
noted in most patients with VS
38. audiological tests
Cochlear Retrocochlear
a) Pure tone audiometry Sensorineural hearing loss Sensorineural hearing loss
b) Speech discrimination
score
<90% Very poor
c) Roll over phenomenon Absent Present
d) Recruitment Present Absent
e) SISI Over 70% 0-20%
f) Threshold tone decay
test
<25db >25db
g) Stapedial reflex Present Absent
i) Stapedial reflex decay
test
Normal Absent
39. VESTIBULAR TESTING
Not sensitive nor specific for diagnosing VS
The MC test used is ENG with caloric testing.
Shows reduced caloric response in the affected ear.
The extent of vestibular function present predicts the
amount of post op vertigo.
The location of VS on the inf or sup Vestibular N may
also be predicted.
40. AUDITORY BRAINSTEM RESPONSE
In patients with VS , the ABR is partially or
completely absent , or there is a delay in
latency of wave V on the affected side.
An interaural delay of wave V greater than
0.2 ms is considered abnormal. ( 40-60 % )
Overall ABR has a sensitivity of > 90% &
specificity of > 90 % in detecting VS.
41. AUDITORY BRAINSTEM RESPONSE
In 20-30 % there are no identifiable
waveforms even with insignificant HL in
higher frequencies.
In 10-20 % only wave I is present.
43. Imaging studies
VS is definitely identified MC via an imaging study.
Earlier plain film radiograghs and polytomographs
Introduction of CT in 1970 allowed axial imaging
with improved bone & soft tissue evaluation.
With the addition of iv iodinated contrast agent
,90 % of VS are enhanced furthur improving
diagnostic accuracy.
44. Imaging studies
Intracanalicular tumors & tumors extending less
than 5 mm into the CPA frequently are missed
with contrast enhanced CT.
Accuracy improved by air-contrast cisternography.
MRI was introduced in 1980 & has become the
GOLD standard for VS
45. Imaging studies
MRI :
VII & VIII nerves as well as cerebellum ,brainstem , vasculature
& other structures are well visualized on MRI
The addition of gadolinium furthur enhanced the diagnostic
accuracy
Typically a series of T1 weighed images in which CSF is dark
and fat is bright, T1 with gadolinium contrast , T2 In which
CSF is bright is used.
A hypointense globular mass centered over the IAC on T1 With
enhancement on gadolinium.
VS are iso-to hypointense on T2.
T2 fast spin echo MRI without contrast as screening.
46. MRI Brain
Isointense to brain,
hyperintense to CSF
Hyperintense to brain,
hypointense to CSF
47. management options
The primary management of VSs is surgical removal.
Roles of observation and radiotherapy are currently for
the pts,who cannot tolerate a surgical procedure or have
a life span of < 5 yrs.
Surgical approaches to the CPA include:
◦ Translabrynthine
◦ Retrosigmoid
◦ Middle fossa craniotomies.
48. management options
The appropriate approach for a particular
pt. is based on the hearing status , size of
the tumor , extent of IAC involvement and
experience of the surgeon
The approaches are either hearing
preservative or ablating.
The retrosigmoid & middle fossa
approaches are hearing preserving, while
translabrynthine approach is otherwise.
49. management options
The middle fossa approach is well suited for the
pts with good hearing and tumor<2cm.
The retrosigmoid approach is well suited for
those with good hearing and tumor<4cm and
not involving the lateral part of IAC.
The translabrynthine approach causes total
hearing loss and so is appropriate for the pts with
poor hearing(PTA>30dB) or pts with good
hearing and tumors not accessible by the hearing
preserving approach.
50. management options
Three critical issues inherent to all the three techniques are:
◦ Extent of exposure of IAC and CPA
◦ Identification and preservation of the facial nerve
◦ extent of brain retraction
These operations use electro physiologic
monitoring of CN VII and ABR in hearing
preserving approach.
52. Translabrynthine approach
The primary approach for removal of VS.
Most direct route to the CPA & requires
minimal cerebellar retraction.
Identification of facial n is possible.
Surgeons can ensure complete removal bcz
fundus of IAC is widely exposed.
Immediate repair of facial n possible.
Recovery is quite rapid with minimal pain and
excellent facial n results
53. Translabrynthine approach
Obvious disadvantage is sacrifice of any residual
hearing.
Technique :
◦ A postauricular incision is made 2 cm behind sulcus
◦ Complete mastoidectomy is done,with identification of
the middle fossa dura, sigmoid sinis , LSSC , fossa incudis
& facial n
◦ The sigmoid sinus is decompressed with a diamond burr
54. Translabrynthine approach
◦ A labrynthectomy is begun by removal of bone in the
sinodural angle along the horizontal scc
◦ Each SCC is then opened and followed into the vestibule,
with care taken to identify the ampulla of each SCC and
the subarcuate artery
◦ A bone is removed along the posterior fossa dura medial
to sigmoid sinus , the endolymphatic duct and sac are
encountered.
55. Translabrynthine approach
◦ Jugular bulb location is defined by locating ampulla of
posterior canal. ( inferior extent of dissection )
◦ Bone is removed around the inferior aspect of IAC until
the cochlear aqueduct is identified
◦ Posterior aspect of the canal is skeletonized until the
superior edge of the internal canal is identified
◦ Bone is then carefully removed between th e middle
fossa dura & the IAC
56. Translabrynthine approach
◦ Once the medial portion of the IAC is exposed for 270
the remaining piece of porus may be carefully removed
◦ Laterally the transverse crest should be identified at the
fundus of the IAC.
◦ Superiorly , the Bills Bar is identified together with the
labrynthine portion of the facial n
◦ The posteroir fossa dura is opened inferior to and parallel
to the superior petrosal sinus over the midportion of the
IAC
0
57. Translabrynthine approach
◦ Using the bills bar as guide , and with a fine hook , the
surgeon seperates the superior vest n from facial nerve.
◦ The capsule of the tumor is incised , & the tumor is
gutted with house urban dissector
0
58.
59. Radiotherapy :-
1. Conventional radiotherapy by external beam
has no role in the treatment of Acoustic Neuromas
due to low tolerance of CNS to radiation.
2. X – or Gamma knife surgery.